Perspectives of commissioners and cancer specialists in prioritising new cancer drugs: impact of the evidence threshold

This publication has 14 references indexed in Scilit:

• Cost of Treating Advanced Colorectal Cancer: A Retrospective Comparison of Treatment Regimens
  European Journal Of Cancer, 1996
• Cancer treatments rationed by authority
  BMJ, 1996
• Post-traumatic stress disorder may follow childbirth
  Published by BMJ ,1996
• Fludarabine in chronic leukaemia
  The Lancet, 1996
• A randomised trial comparing two doses of the new selective aromatase inhibitor anastrozole (Arimidex) with megestrol acetate in postmenopausal patients with advanced breast cancer *
  European Journal Of Cancer, 1996
• Cyclophosphamide and Cisplatin Compared with Paclitaxel and Cisplatin in Patients with Stage III and Stage IV Ovarian Cancer
  New England Journal of Medicine, 1996
• Gemcitabine: clinical and economic impact in inoperable non-small cell lung cancer
  Anti-Cancer Drugs, 1995
• A purchaser perspective of managing new drugs: interferon beta as a case study
  BMJ, 1995
• The Golem: What Everyone Should Know about Science.
  Contemporary Sociology: A Journal of Reviews, 1995
• Liposomal amphotericin B in the treatment of fungal infections in neutropenic patients: a single‐centre experience of 133 episodes in 116 patients
  British Journal of Haematology, 1994